Our active ingredient is Innovation

At Merck Serono, we are actively committed to bringing therapeutic innovations to patients. We specialise in the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases and other conditions with unmet medical needs.

Around the world, over 17,000 employees work to discover, develop, manufacture and commercialise Merck Serono’s prescription therapies, available in over 150 countries.

We are internationally recognised as a biotechnology leader, with innovative and successful products along with a well-stocked and promising development pipeline. Specialised know-how in research and production means that we are able to ensure absolutely high-quality manufacturing, a key success factor especially in the biopharmaceutical industry.

In 2007, sales of Merck Serono products generated total revenues of € 4.5 billion. We devote 20% of these earnings to the pursuit of innovative new therapies through our own research and development, strategic alliances and agreements.

The Merck Serono division website can be found under www.merckserono.com